DK1210943T3 - Ny anvendelse af budesonid og formoterol - Google Patents

Ny anvendelse af budesonid og formoterol

Info

Publication number
DK1210943T3
DK1210943T3 DK02001670T DK02001670T DK1210943T3 DK 1210943 T3 DK1210943 T3 DK 1210943T3 DK 02001670 T DK02001670 T DK 02001670T DK 02001670 T DK02001670 T DK 02001670T DK 1210943 T3 DK1210943 T3 DK 1210943T3
Authority
DK
Denmark
Prior art keywords
formoterol
budesonide
new use
new
Prior art date
Application number
DK02001670T
Other languages
Danish (da)
English (en)
Inventor
Carl-Axel Bauer
Jan Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20408325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1210943(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1210943T3 publication Critical patent/DK1210943T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK02001670T 1997-09-19 1998-09-09 Ny anvendelse af budesonid og formoterol DK1210943T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703407A SE9703407D0 (sv) 1997-09-19 1997-09-19 New use
PCT/SE1998/001599 WO1999015182A1 (en) 1997-09-19 1998-09-09 New use for budesonide and formoterol

Publications (1)

Publication Number Publication Date
DK1210943T3 true DK1210943T3 (da) 2006-09-18

Family

ID=20408325

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98944373T DK1014993T3 (da) 1997-09-19 1998-09-09 Hidtil ukendt anvendelse af budesonid og formoterol
DK02001670T DK1210943T3 (da) 1997-09-19 1998-09-09 Ny anvendelse af budesonid og formoterol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK98944373T DK1014993T3 (da) 1997-09-19 1998-09-09 Hidtil ukendt anvendelse af budesonid og formoterol

Country Status (38)

Country Link
US (2) US7897646B2 (ru)
EP (2) EP1014993B1 (ru)
JP (1) JP2001517630A (ru)
KR (1) KR20010024140A (ru)
CN (1) CN1149998C (ru)
AR (1) AR013506A1 (ru)
AT (2) ATE329599T1 (ru)
AU (1) AU757235B2 (ru)
BR (1) BR9812325A (ru)
CA (1) CA2302700C (ru)
CY (1) CY1106156T1 (ru)
CZ (1) CZ295250B6 (ru)
DE (2) DE69807239T2 (ru)
DK (2) DK1014993T3 (ru)
EE (1) EE04297B1 (ru)
ES (2) ES2266322T3 (ru)
HK (1) HK1045812B (ru)
HU (1) HUP0003848A2 (ru)
ID (1) ID24838A (ru)
IL (1) IL134773A (ru)
IN (1) IN190791B (ru)
IS (1) IS2715B (ru)
MX (1) MXPA00002615A (ru)
MY (1) MY127812A (ru)
NO (1) NO327176B1 (ru)
NZ (1) NZ503173A (ru)
PL (1) PL190782B1 (ru)
PT (2) PT1014993E (ru)
RU (1) RU2199322C2 (ru)
SA (1) SA98190773B1 (ru)
SE (1) SE9703407D0 (ru)
SI (2) SI1014993T1 (ru)
SK (1) SK285330B6 (ru)
TR (1) TR200000726T2 (ru)
TW (1) TW546140B (ru)
UA (1) UA72446C2 (ru)
WO (1) WO1999015182A1 (ru)
ZA (1) ZA988516B (ru)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
SK284889B6 (sk) * 1998-11-13 2006-02-02 Jago Research Ag Použitie stearátu horečnatého v suchých práškových formuláciách na inhaláciu
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9928311D0 (en) 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
DE60221640T2 (de) * 2001-02-06 2008-05-21 Innovata Biomed Ltd., St. Albans Bimodale trockenpulverzusammensetzung zur inhalation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
AU2003279070A1 (en) * 2002-09-30 2004-04-23 Acusphere Inc Sustained release porous microparticles for inhalation
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
AU2006270165B2 (en) 2005-07-14 2010-03-11 Neothetics, Inc. Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
JP2009519970A (ja) * 2005-12-15 2009-05-21 アキュスフィア， インコーポレイテッド 粒子ベースの経口投与用製薬剤形の製造方法
US7913223B2 (en) * 2005-12-16 2011-03-22 Dialogic Corporation Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
ES2398480T3 (es) * 2006-10-17 2013-03-19 Lithera, Inc. Procedimientos, composiciones, y formulaciones para el tratamiento de la enfermedad ocular tiroidea
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PL3106149T3 (pl) 2009-05-29 2020-06-01 Pearl Therapeutics, Inc. Kompozycje do płucnego dostarczania długo-działających antagonistów muskarynowych i długo-działających agonistów receptora beta-2 adrenergicznego oraz powiązane sposoby i układy
CA2764867C (en) * 2009-06-09 2016-05-17 Elevation Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
CN102000090A (zh) * 2009-08-31 2011-04-06 北京利乐生制药科技有限公司 一种以布地奈德与阿福特罗为活性成分的复方制剂
GB2487868B (en) * 2010-01-15 2014-12-10 Neothetics Inc Lyophilized cake formulations
TW201231042A (en) 2010-11-24 2012-08-01 Lithera Inc Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
CA2830069C (en) 2011-03-20 2019-11-12 The University Of British Columbia Therapeutic agent for emphysema and copd
CN102362860A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德和福莫特罗气雾剂制剂
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
ITMI20130571A1 (it) * 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
GB201321712D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
ES2796177T3 (es) 2015-12-04 2020-11-26 Mexichem Fluor Sa De Cv Composición farmacéutica
CA3103679A1 (en) 2018-06-14 2019-12-19 Astrazeneca Uk Limited Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition
WO2021048171A1 (en) * 2019-09-10 2021-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to improve phagocytosis

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE92762T1 (de) 1989-09-08 1993-08-15 Glaxo Group Ltd Medikamente.
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
US5250286A (en) * 1990-05-07 1993-10-05 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
PL164294B1 (pl) 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5444521A (en) 1991-07-15 1995-08-22 Canon Kabushiki Kaisha Image fixing device capable of controlling heating overshoot
EP1101493A3 (en) 1991-12-18 2004-01-14 AstraZeneca AB New combination of formoterol and budesonide
SG48301A1 (en) * 1991-12-18 1998-04-17 Astra Ab New combination
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
GB9519692D0 (en) * 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
JP2000501104A (ja) * 1995-11-24 2000-02-02 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ キノリン誘導体
SE9603669D0 (sv) 1996-10-08 1996-10-08 Astra Ab New combination
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
WO1999000134A1 (en) 1997-06-27 1999-01-07 Astra Aktiebolag (Publ) New combination of antiasthma medicaments
SE9703407D0 (sv) * 1997-09-19 1997-09-19 Astra Ab New use
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination

Also Published As

Publication number Publication date
ES2266322T3 (es) 2007-03-01
EE200000145A (et) 2001-02-15
ZA988516B (en) 1999-03-19
NZ503173A (en) 2001-08-31
DE69807239D1 (de) 2002-09-19
NO20001401L (no) 2000-03-17
ID24838A (id) 2000-08-24
CA2302700A1 (en) 1999-04-01
NO20001401D0 (no) 2000-03-17
ES2182357T3 (es) 2003-03-01
EP1210943B1 (en) 2006-06-14
US7897646B2 (en) 2011-03-01
MY127812A (en) 2006-12-29
AU757235B2 (en) 2003-02-06
AR013506A1 (es) 2000-12-27
EE04297B1 (et) 2004-06-15
ATE222106T1 (de) 2002-08-15
CZ2000950A3 (cs) 2000-06-14
HK1045812B (zh) 2006-12-22
EP1014993B1 (en) 2002-08-14
CN1271287A (zh) 2000-10-25
SA98190773B1 (ar) 2006-10-02
SI1210943T1 (sl) 2006-10-31
SK285330B6 (sk) 2006-11-03
IN190791B (ru) 2003-08-23
ATE329599T1 (de) 2006-07-15
CN1149998C (zh) 2004-05-19
PL190782B1 (pl) 2006-01-31
PT1210943E (pt) 2006-09-29
SI1014993T1 (en) 2003-02-28
NO327176B1 (no) 2009-05-04
DK1014993T3 (da) 2002-11-11
AU9192898A (en) 1999-04-12
US20110097282A1 (en) 2011-04-28
IL134773A (en) 2005-03-20
SE9703407D0 (sv) 1997-09-19
HUP0003848A2 (hu) 2001-08-28
HK1045812A1 (en) 2002-12-13
SK3892000A3 (en) 2000-12-11
KR20010024140A (ko) 2001-03-26
RU2199322C2 (ru) 2003-02-27
DE69807239T2 (de) 2003-04-10
EP1014993A1 (en) 2000-07-05
PT1014993E (pt) 2002-12-31
TR200000726T2 (tr) 2000-09-21
CY1106156T1 (el) 2011-06-08
DE69834955T2 (de) 2007-01-25
UA72446C2 (ru) 2005-03-15
IS2715B (is) 2011-02-15
EP1210943A1 (en) 2002-06-05
US20060189587A9 (en) 2006-08-24
DE69834955D1 (de) 2006-07-27
BR9812325A (pt) 2000-09-05
CZ295250B6 (cs) 2005-06-15
JP2001517630A (ja) 2001-10-09
WO1999015182A1 (en) 1999-04-01
MXPA00002615A (es) 2002-04-24
IS5407A (is) 2000-03-15
IL134773A0 (en) 2001-04-30
US20020042404A1 (en) 2002-04-11
US8461211B2 (en) 2013-06-11
PL339295A1 (en) 2000-12-04
CA2302700C (en) 2010-11-23
TW546140B (en) 2003-08-11

Similar Documents

Publication Publication Date Title
DK1210943T3 (da) Ny anvendelse af budesonid og formoterol
DE60010662D1 (de) Kombinationen von formoterol und fluticasonpropionat für asthma
ATE252832T1 (de) Kombinationen aus herbiziden und safenern
NO20022334L (no) Ny sammensetning og anvendelse
NO991151D0 (no) Forbindelse og anvendelse derav
NO993068D0 (no) Ny forbindelsesform
NO20002846L (no) Inhaleringsanordning og fremgangsmÕte ved samme
NO984094D0 (no) Utladningsreaktor og anvendelse av samme
DK0815861T3 (da) Sulfonamider og anvendelse deraf
NO972125D0 (no) Hemmoroideblandinger og fremgangsmåte for anvendelse
IS5510A (is) Efnasambönd sem verka gegn "picorna"-veirum og aðferðir til nota þeirra og smíða
DK1112003T3 (da) Ny sammensætning og anvendelse
DK1216046T3 (da) Hidtil ukendt kombination af loteprednol og antihistaminer
DE69819193D1 (de) Dehnungsmessstreifen und dessen anwendungen
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
NO20006626D0 (no) Beleggingsmiddel og anvendelse herav
DE69830259D1 (de) Gewebeschutzmittel und der Gebrauch desselben
DE69817233T8 (de) Mischungen aus fluorierten Elastomeren und Acrylelastomeren
DK75994A (da) Klæbemiddel samt anvendelse af dette middel
EE9800282A (et) Seade vedeliku väljastamiseks ja elastne veniv mansett
NO20010470D0 (no) Koplingsinnretning og anvendelse av samme
DE29817550U1 (de) Dosiervorrichtung sowie Anwendung derselben
ID30541A (id) Peptida-peptida kecil dan penggunannya pada penyembuhan asma dan radang
NO20014454D0 (no) Konstruksjon og anvendelse av samme